TCTC Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Hold
2,003
0.01% 201
2026
Q1
$256K Hold
2,003
0.01% 202
2025
Q4
$244K Hold
2,003
0.01% 205
2025
Q3
$201K Hold
2,003
0.01% 207
2025
Q2
$166K Hold
2,003
0.01% 221
2025
Q1
$162K Hold
2,003
0.01% 219
2024
Q4
$180K Buy
2,003
+53
+3% +$5.13K 0.01% 211
2024
Q3
$193K Hold
1,950
0.01% 205
2024
Q2
$181K Hold
1,950
0.01% 210
2024
Q1
$185K Sell
1,950
-3
-0.2% -$278 0.01% 197
2023
Q4
$174K Hold
1,953
0.01% 199
2023
Q3
$143K Sell
1,953
-20
-1% -$1.6K 0.01% 196
2023
Q2
$164K Hold
1,973
0.01% 194
2023
Q1
$150K Buy
1,973
+23
+1% +$1.91K 0.01% 208
2022
Q4
$162K Hold
1,950
0.01% 188
2022
Q3
$155K Hold
1,950
0.01% 186
2022
Q2
$145K Hold
1,950
0.01% 198
2022
Q1
$175K Hold
1,950
0.01% 193
2021
Q4
$218K Hold
1,950
0.01% 196
2021
Q3
$245K Hold
1,950
0.01% 179
2021
Q2
$264K Hold
1,950
0.01% 168
2021
Q1
$265K Hold
1,950
0.01% 158
2020
Q4
$275K Hold
1,950
0.01% 157
2020
Q3
$217K Hold
1,950
0.01% 158
2020
Q2
$218K Buy
+1,950
New +$192K 0.01% 158
2015
Q3
Sell
-2,463
Closed -$207K 186
2015
Q2
$207K Buy
+2,463
New +$192K 0.01% 164

Other funds holding XBI

TCTC Holdings's XBI Position: Q2 2026 in Review

TCTC Holdings held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,003 shares worth $317K. The position accounts for 0.01% of the portfolio, ranked #201.

TCTC Holdings first reported a position in XBI in Q2 2015 and has held it in 26 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • TCTC Holdings held 2,003 shares of State Street SPDR S&P Biotech ETF worth $317K as of Q2 2026.
  • TCTC Holdings left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of TCTC Holdings's portfolio in Q2 2026, its #201 holding.
  • TCTC Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and has held it in 26 quarters since.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on TCTC Holdings's 13F filing for Q2 2026, filed 11 Aug 2026.